Clinical Research Directory
Browse clinical research sites, groups, and studies.
Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions
Sponsor: M.D. Anderson Cancer Center
Summary
This clinical trial studies contrast-enhanced magnetic resonance imaging (MRI) in detecting nonmalignant and malignant liver lesions. Diagnostic procedures, such as MRI, may help find and diagnose nonmalignant and malignant liver lesions. Contrast agents, such as gadoxetate disodium and gadobutrol, may help doctors to see MRI images more clearly.
Official title: Radiologic Detection and Characterization of Benign and Malignant Liver Lesions in Contrast-Enhanced MRI
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2014-10-13
Completion Date
2026-06-01
Last Updated
2025-12-22
Healthy Volunteers
No
Conditions
Interventions
Contrast-enhanced Magnetic Resonance Imaging
Undergo contrast-enhanced MRI
Gadobutrol
Given IV
Gadoxetate Disodium
Given IV
Locations (1)
M D Anderson Cancer Center
Houston, Texas, United States